2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation - Top-Institutions - MDSpire

2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation

  • By

  • Masthan Thamim

  • Debdas Dhabal

  • M. M. Balamurali

  • Krishnan Thirumoorthy

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Cancer Metabolism
    • Molecular Oncology
    • Translational Research
  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Biology
    • Metabolic Therapeutics
    • Epigenetics
  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cancer Metabolism
    • Molecular Oncology
    • Clinical Trials
  • #4

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Cancer Genomics
    • Metabolomics
    • Epigenetics
  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Cancer Metabolism
    • Molecular Oncology
    • Translational Medicine

Original Source(s)

Related Content